FindTrial
Sign In

In-hospital and midterm outcomes of bilateral in situ skeletonized internal mammary arteries bypass grafting

In-hospital and midterm outcomes of bilateral in situ skeletonized internal mammary arteries bypass grafting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012485
Enrollment
Unknown
Registered
2017-08-27
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Bilateral IMA group:Bilateral in situ sleletonized IMAs bypass grafting
Single IMA group:Single in situ skeletonized IMA bypass grafting

Sponsors

Department of Cardiac surgery, Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with coronary artery disease who suffered from triple-vessel disease receiving first, scheduled, isolated CABG procedure with bilateal or single in situ skeletonized internal mammary artery grafting; less than 70 years old

Exclusion criteria

Exclusion criteria: Patients were excluded from this study on the basis of the following criteria: any concomitant diseases including renal insufficiency, malignant tumor, and chronic obstructive pulmonary disease; and a history of chest radiotherapy. Patients who failed to receive dual antiplatelet therapy were also excluded from this study.

Design outcomes

Primary

MeasureTime frame
Surgical mortality;Major postoperative morbidity;Follow-up survival;Repeat vascularization;IMA graft patency;—

Countries

China

Contacts

Public ContactQiang Ji

Department of Cardiac surgery, Zhongshan Hospital Fudan University

ji.qiang@zs-hospital.sh.cn+86 15921230800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026